The results showed that the CML treatment, a major AGE, also causes the production of yellowish fluorescence and exposure of Trp in apoA-I toward the aqueous phase, similar to a fructose treatment. Here, APOA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.